Petition Demands Accountability From Generic and Brand Name Drug Manufacturers
March 11, 2014
Millions of Americans depend on medications to treat their conditions and ailments. For many, purchasing generic versions of brand name medications is one way to keep medical costs down. In fact, 80 percent of prescriptions are filled using a generic form of a drug. But doing so may put consumers at risk, because makers of generic and brand name medications are held to different safety standards under current U.S. law.
Similar brand name and generic drugs are required to carry the same warning label. However, if a risk of harm is discovered after the drug’s release, the generic drug makers cannot change a warning label until the brand name manufacturer makes the change. The rule also prevents generic drug manufacturers from being held accountable in court when a generic drug is responsible for harming a patient.
The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough believe manufacturers of both generic and brand name medications should be held accountable for the harm caused by their products. That is why the firm is asking citizens to call on the U.S. Food and Drug Administration (FDA) to take action against this problem.
Take Justice Back is hoping to raise enough signatures on a petition demanding the FDA hold generic drug manufacturers to the same warning label standards brand name makers face.
The attorneys with Ferrer, Poirot & Wansbrough ask that each citizen demand accountability from all drug manufacturers by signing the petition for change.